Anaesthesia for Carcinoid Syndrome
نویسندگان
چکیده
منابع مشابه
Remifentanil and anaesthesia for carcinoid syndrome.
Carcinoid syndrome creates many challenges during anaesthesia, including hypertension, hypotension and bronchospasm. These challenges are less common and less severe after the routine use of octreotide. We describe the use of remifentanil as part of the anaesthetic management of a 67-yr-old man undergoing resection of a carcinoid tumour of the terminal ileum. The combination of perioperative oc...
متن کاملAnaesthesia for the carcinoid syndrome: a report of nine cases.
Anaesthesia for nine patients with the carcinoid syndrome is described. With the exception of one case in which severe bronchospasm and hypertension occurred, complications were minor. Steroids, aprotonin and methotrimeprazine appear to be useful agents in the management of such patients. An anaesthetic technique employing thiopentone, pancuronium and nitrous oxide proved satisfactory.
متن کاملIntra-operative carcinoid crisis: Revised anaesthesia management
Carcinoid is a tumour of amine precursor uptake and decarboxylation cells.[1] Tumours arise in the gastrointestinal tract (67.5%) and the bronchopulmonary system (25.3%). Pulmonary carcinoids account for 2% of all primary lung cancers with a 10-year survival of 82%–92%.[2] Bronchial carcinoids are perihilar and present with chest pain but can present as asthma, recurrent pneumonia, cough or hae...
متن کاملAnesthesia for the carcinoid syndrome.
The first report of an association between a carcinoid tumor and a specific syndrome was reported by Biorck and associates in 1952. 6 Since that time, literature on the carcinoid syndrome has appeared more frequently. In 1976, Mason and Steane published two review articles on the subject which have served as reference guides for anesthesia personnel.6' 7 Fewer than 50 cases of the carcinoid syn...
متن کاملThe Carcinoid Syndrome
THE first description of a carcinoid tumour was as early as 1888 (Lubarsch). Later attention was drawn to the possibility that the cells of these tumours (known as argentaffinomas) act as secretors of some "endocrine" substance. "Enteramine" or "serotonin" (5 hydroxytryptamine or 5 H.T.) was later isolated from carcinoid tumours and recently its degradation product-5 hydroxy-indoleacetic acid o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the Royal Society of Medicine
سال: 1996
ISSN: 0141-0768,1758-1095
DOI: 10.1177/014107689608900520